Immix Biopharma, Inc.
Company Stats
- Market Cap
- $744.4M
- as of Sep 30, 2026
- Shares Outstanding
- 71.5M
- Free Float
- 83.9%
Income Statement
- Operating Income
- -$30.0M
- Net Income
- -$29.4M
- EBITDA
- -$29.7M
Cash Flow
- Free Cash Flow
- -$24.7M
- FCF Yield
- -3.3%
- Owner FCF Yield
- -3.6%
Balance Sheet
- Cash & Equivalents
- $93.9M
Returns & Capital
- SBC, 3Y Avg
- $2.7M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | — | -$24.7M | — |
| FY2024 | — | -$15.8M | — |
| FY2023 | — | -$11.4M | — |
| FY2021 | — | -$1.6M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of October 6, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.